Pfizer’s Lorbrena scores US priority review by Lucy Parsons | Jan 4, 2021 | News | 0 Drug is being reviewed for ALK-positive lung cancer Read More
Pfizer’s new lung cancer drug bags US clearance by Selina McKee | Nov 5, 2018 | News | 0 Pfizer’s new lung cancer treatment Lorbrena has bagged US approval for previously treated patients with a specific gene mutation and metastatic disease. Read More